论文信息 - A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia - 字舞流文

A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia

G. Acton | A. Boddy | P. Kearns | U. Banerji | J. Irving | D. Hargrave | C. Harrison | C. Schwab | A. Moore | M. Case | L. Minto | G. Veal | J. Vormoor | K. Swales | M. Griffin | B. Vormoor | J. Tall | M. Toguchi | K. Dyer | J. Grainger | D. Lancaster | M. Griffin | Pamela R. Kearns | Marian Case | Mj Griffin | Andrew S. Moore | Darren Hargrave | Christine J. Harrison | D. Lancaster | Julie Irving | Jennifer R. Tall | Gary Acton | John R. Grainger